AR
Anupam Rama JP Morgan Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
63
Avg Return
Past Year
Past Year
22%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
87.5%
Neutral
12.5%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Upgraded
| $12 |
280%
upside
| 1 | +68% |
0
%
| 16 Mar ‘26 2 months ago |
|
|
|
Overweight
Maintained
| $177 |
14%
upside
| 3 | +1.8% |
0
%
| 12 Mar ‘26 2 months ago |
|
|
|
Overweight
Maintained
| $74 |
240%
upside
| 1 | -22% |
0
%
| 12 Mar ‘26 2 months ago |
|
|
|
Neutral
Downgraded
| $21.50 |
0%
downside
| 1 | +137% |
0
%
| 11 Mar ‘26 2 months ago |
|
|
|
Overweight
Maintained
| $94 |
47%
upside
| 1 | +21% |
0
%
| 10 Mar ‘26 2 months ago |
|
|
|
Overweight
Maintained
| $45 |
145%
upside
| 1 | +23% |
0
%
| 9 Mar ‘26 2 months ago |
|
|
|
Overweight
Maintained
| $37 |
10%
downside
| 1 | -6.1% |
0
%
| 5 Mar ‘26 2 months ago |
|
|
|
Overweight
Initiated
| $32 |
171%
upside
| 1 | -11% |
0
%
| 3 Mar ‘26 3 months ago |
|